IBCRF awards TGen $50,000 to discover genetic origins of inflammatory breast cancer
The Inflammatory Breast Cancer Research Foundation (IBCRF) has awarded $50,000 to the Translational Genomics Research Institute (TGen) to discover the genetic origins of this rare and most deadly form of breast cancer.